Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

serotonin/vomissement

Le lien est enregistré dans le presse-papiers
Page 1 de 39 résultats

Stimulation of serotonin-1A receptors in mammals to alleviate motion sickness and emesis induced by chemical agents

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This invention relates to a method of alleviating both motion sickness and emesis induced by chemical agents, and more particularly to the use of compositions which stimulate serotonin-1A receptors in mammals to achieve this purpose. There are currently no known strategies or agents which are
1. INTRODUCTION The present invention relates to a novel method of controlling nausea and vomiting (or emesis) in mammals utilizing certain substituted-phenylalkylamino (and aminoacid) derivatives which do not exhibit certain side effects of the type attributable to dopamine blocking compounds which

Pharmaceutical compositions containing quinazoline derivatives for treating as serotonin receptor antagonist

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
CROSS-REFERENCE TO RELATED APPLICATION This application claims, under 35 U.S.C. .sctn.119(a), the benefit of Korean Patent Application No. 10-2007-0084322 filed Aug. 22, 2007, the entire contents of which are incorporated herein by reference. BACKGROUND OF THE INVENTION 1. Field of the Invention The

Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION Dopamine is a neurotransmitter found in various parts of the central nervous system. It is most prevalent in the substantia nigra (A9), the neostriatum, and the ventral tegmental area (A10). Dopamine binds to two general classes of receptors, termed D1- and D2-like

Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION Dopamine is a neurotransmitter found in various parts of the central nervous system. It is most prevalent in the substantia nigra (A9), the neostriatum, and the ventral tegmental area (A10). Dopamine binds to two general classes of receptors, termed D1- and D2-like

Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION Dopamine is a neurotransmitter found in various parts of the central nervous system. It is most prevalent in the substantia nigra (A9), the neostriatum, and the ventral tegmental area (A10). Dopamine binds to two general classes of receptors, termed D1- and D2-like

Methods for treating emesis and nausea using optically pure R(+) ondansetron

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION This invention relates to novel compositions of matter containing optically pure R(+) ondansetron. These novel compositions have potent antiemetic activity and are useful in ameliorating the nausea and vomiting otherwise induced by cancer chemotherapeutic agents and

4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This application claims the benefit of Provisional Application 60/069,890 Jan. 5, 1996. The present invention is directed to certain novel compounds and their use as pharmaceutical agents having unique central nervous system activity. This invention relates to 4,5-dihydronaphth[1,2-c]isoxazoles and

Naphthothiopyranone derivatives

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
DESCRIPTION 1. Technical Field The present invention relates to naphthothiopyranone derivatives, and more particularly relates to naphthothiopyranone derivatives having the antagonist effect of 5-HT (serotonin) at 5-HT.sub.3 (serotonin 3) receptors. Background Art Compounds described in EP-A-364274

2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivatives, and production method and use thereof

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This application is a 371 of PCT/JP93/01589 filed Nov. 4, 1993. 1. Technical Field The present invention relates to novel 2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivatives, a production method thereof, and a pharmaceutical use thereof. The 2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivatives are

Deuterium-enriched pyridinonecarboxamides and derivatives

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
SUMMARY OF THE INVENTION The present invention is concerned with deuterium-enriched pyridinone carboxamides and derivatives thereof of formula I, ##STR00002## Wherein, R.sub.1 and R.sub.2 are independently, H, D (deuterium with enrichment of 1%-100%), F, Cl, CD.sub.3 (methyl-d.sub.3),

Deuterium-enriched pyridinonecarboxamides and derivatives

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
SUMMARY OF THE INVENTION The present invention is concerned with deuterium-enriched pyridinonecarboxamides and derivatives thereof of formula 1, ##STR00002## Wherein, R.sub.1 and R.sub.2 are independently, H, D (deuterium with enrichment of 1%-100%), F, Cl, CD.sub.3 (methyl-d.sub.3),

Ligands for monoamine receptors and transporters, and methods of use thereof

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION Dopamine, norepinephrine and serotonin are mammalian monoamine neurotransmitters that play important roles in a wide variety of physiological processes. Therefore, compounds that selectively modulate the activity of these three neurotransmitters, either individually, in

Ligands for monoamine receptors and transporters, and methods of use thereof

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION Dopamine, norepinephrine and serotonin are mammalian monoamine neurotransmitters that play important roles in a wide variety of physiological processes. Therefore, compounds that selectively modulate the activity of these three neurotransmitters, either individually, in

Ligands for monoamine receptors and transporters, and methods of use thereof

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION Dopamine, norepinephrine and serotonin are mammalian monoamine neurotransmitters that play important roles in a wide variety of physiological processes. Therefore, compounds that selectively modulate the activity of these three neurotransmitters, either individually, in
Rejoignez notre
page facebook

La base de données d'herbes médicinales la plus complète soutenue par la science

  • Fonctionne en 55 langues
  • Cures à base de plantes soutenues par la science
  • Reconnaissance des herbes par image
  • Carte GPS interactive - étiquetez les herbes sur place (à venir)
  • Lisez les publications scientifiques liées à votre recherche
  • Rechercher les herbes médicinales par leurs effets
  • Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets

Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées

Google Play badgeApp Store badge